Article Information
vol. 41 no. 5 1107-1115
PubMed
Published By
Print ISSN
Online ISSN
History
- Received May 4, 2012
- Accepted September 15, 2012
- Published online April 30, 2013.
Article Versions
- previous version (September 27, 2012 - 09:25).
- previous version (October 11, 2012 - 10:22).
- previous version (December 20, 2012 - 07:17).
- You are viewing the most recent version of this article.
Copyright & Usage
©ERS 2013 ERJ Open articles are open access and distributed under the terms of the (Creative Commons Attribution Non-Commercial Licence 3.0)
Author Information
- Robert Wilson*⇑,
- Tobias Welte#,
- Eva Polverino¶,
- Anthony De Soyza+,
- Hugh Greville§,
- Anne O'Donnellf,
- Jeff Alder**,
- Peter Reimnitz## and
- Barbara Hampel¶¶
- *Host Defence Unit, Royal Brompton Hospital, London
- +Newcastle University and Freeman Hospital, Newcastle upon Tyne, UK
- #Hannover Medical School, Hannover
- ##Bayer Pharma AG, Wuppertal
- ¶¶Bayer Pharma AG, Berlin, Germany
- ¶Hospital Clinic de Barcelona IDIBAPS, CIBERES, Barcelona, Spain
- §Royal Adelaide Hospital, Adelaide, Australia
- fGeorgetown University Hospital, Washington, DC,
- **Bayer HealthCare Pharmaceuticals Inc., Montville, NJ, USA
- R. Wilson, Royal Brompton Hospital, London SW3 6NP, UK. E-mail: r.wilson{at}rbht.nhs.uk
Article usage
Altmetrics
Vol 41 Issue 5
Table of Contents
Ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis: a phase II randomised study
